KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Non-Current Assets: 2009-2025

Historic Non-Current Assets for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $80.7 billion.

  • Thermo Fisher Scientific's Non-Current Assets rose 5.41% to $80.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $80.7 billion, marking a year-over-year increase of 5.41%. This contributed to the annual value of $75.2 billion for FY2024, which is 1.41% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Non-Current Assets is $80.7 billion, which was up 5.32% from $76.6 billion recorded in Q2 2025.
  • Thermo Fisher Scientific's Non-Current Assets' 5-year high stood at $80.7 billion during Q3 2025, with a 5-year trough of $48.2 billion in Q2 2021.
  • In the last 3 years, Thermo Fisher Scientific's Non-Current Assets had a median value of $74.4 billion in 2023 and averaged $75.3 billion.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 59.27% in 2021, then fell by 4.11% in 2022.
  • Thermo Fisher Scientific's Non-Current Assets (Quarterly) stood at $75.0 billion in 2021, then fell by 4.11% to $71.9 billion in 2022, then grew by 3.08% to $74.1 billion in 2023, then rose by 1.41% to $75.2 billion in 2024, then increased by 5.41% to $80.7 billion in 2025.
  • Its last three reported values are $80.7 billion in Q3 2025, $76.6 billion for Q2 2025, and $75.7 billion during Q1 2025.